FindTrial
Sign In

Comparison of high dose rapid schedule with conventional schedule chemotherapy for stage IV neuroblastoma over the age of one year

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67769193
Enrollment
Unknown
Registered
2001-07-01
Start date
1995-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain and nervous system cancer Cancer Brain and nervous system

Interventions

1. Regimen A: Conventional dose and schedule chemotherapy (OPEC/OJEC) 2. Regimen B: Rapid high dose schedule chemotherapy (Rapid COJEC)

Sponsors

Cancer Research UK (CRUK) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Biopsy proven stage IV neuroblastoma 2. Over 1 year of age at diagnosis 3. No previous chemotherapy

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026